← back to search

Wei Cui

Chinese Academy of Medical Sciences & Peking Union Medical College · CN
Area of research
Molecular Biology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Renal and related cancers, RNA modifications and cancer, Epigenetics and DNA Methylation, and Acute Lymphoblastic Leukemia research.
h-index
27
citations
2,384
works
121
NIH funding
primary concept
email

Recent publications

Evaluating the UCP1 expression of brown adipose tissue by quantifying hepatic inflammation using synthetic magnetic resonance imaging: an experimental study with a mouse model
Quantitative Imaging in Medicine and Surgery 2025cited by 0position: middledoi
Additional file 4 of Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients
Figshare 2023cited by 0position: middledoi
Additional file 5 of Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients
Figshare 2023cited by 0position: middledoi
Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma
Gut 2021cited by 270position: lastdoi
YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation
Cells 2021cited by 33position: lastdoi
Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer
International Journal of Cancer 2014cited by 94position: lastdoi
Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization
Clinica Chimica Acta 2014cited by 50position: lastdoi
Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes
Journal of Hematology & Oncology 2013cited by 33position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2014–2021)Ye Guo · Army Medical University3 papers (2013–2014)Zhuo Yang · Jilin University3 papers (2013–2014)Lei Yu · Shanghai Medical College of Fudan University2 papers (2023–2023)Ning Ning · Ningbo University2 papers (2013–2014)Mengjie Cai · Jiangsu University2 papers (2023–2023)Yunju Ma · Soochow University2 papers (2023–2023)Xiaoying Lou · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2021–2021)Ting Zhan · Nanchang University2 papers (2014–2014)Xiaowen Tang · Nanjing University of Chinese Medicine2 papers (2023–2023)Xiaying Lian · Soochow University2 papers (2023–2023)Donghong Zhang · Wuhan University2 papers (2014–2021)Sining Liu · Soochow University2 papers (2023–2023)Qingya Cui · Jinan University2 papers (2023–2023)Haiping Dai · Nanjing University of Chinese Medicine2 papers (2023–2023)Jia Yin · Tianjin University of Traditional Chinese Medicine2 papers (2023–2023)Liqing Kang · Standard Bio (Norway)2 papers (2023–2023)Fei Wang · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2013–2014)Depei Wu · Soochow University2 papers (2023–2023)Lingling Liu · Nationwide Children's Hospital2 papers (2023–2023)